letterNatureNov 1, 2004Closed access

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

ALK-Abelló (Germany) · Alnylam Pharmaceuticals (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,176
total citations
FWCI
56.65
Percentile
100%
References
22
Citations per year

Authors

25

Topics & keywords

Keywords
  • Small interfering RNA
  • Gene silencing
  • RNA interference
  • RNA silencing
  • Systemic administration
  • Apolipoprotein B
  • Biology
  • Cell biology
No related works found for this paper.